1Lindvall O, Hagell P. Cell replacement therapy in human neurodegenerative disorders[J] .Clin Neurosci Res,2002,2:86-92.
2Peterson DA, Stem cells in brain plasticity and repair[J]. Current Opinion in Pharmacology,2002,2:34-42.
3Armstrong PJE, Barker RA.Neurodegeneration :a failure of neuroregeneration[J].Lancet, 2001,358:1174-1176.
4Bjorklund LM, Sanchez O, Pernaute R, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model[J] .Proc Natl Acad Sci U S A,2002,99:2344.-2452.
5Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al.Dopamine neurons derived from embryonic stem cell function in an animal model of Parkinson' s disease[J]. Nature, 2002,418 :50-56.
6Takagi Y, Takahashi J,Saiki H, et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model[J] .J Clin Invest.2005,115:102-109.
7Yah J,Studer L, McKay RDG. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors[J] .J Neurochem,2001,76:307-311.
8Lie DC, Dziewczapolski G, Willhoitel AR, et al. The adult substantia nigra contains progenitor cells with neurogenic potential[J].J Neurosci, 2002,22: 6639-6649.
